Teriflunomide Tablet, Film Coated
Product Images NDC 42291-830

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 42291-830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

30 (830 30)

30 (830 30)
FDA Label Image

30 (831 30)

30 (831 30)
FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

1 (Image 2)

1 (Image 2)
This appears to be a table illustrating clinical trial data related to teriflunomide, with doses of 7mg and 14mg compared to a placebo. The table shows the number of individuals at risk during different weeks of the trial, and includes statistics related to the efficacy of teriflunomide compared to the placebo. The percentage values in parentheses appear to relate to the reduction in risk provided by teriflunomide compared to the placebo. The text does not provide enough context to determine what specific condition or disease is being studied through this trial.*
FDA Label Image

1 (Image 3)

1 (Image 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.